Pharmacogenomics: Role in Medicines Approval and Clinical Use

Publisher： Karger

E-ISSN： 1662-8063|13|5|284-291

ISSN： 1662-4246

Source： Public Health Genomics, Vol.13, Iss.5, 2009-10, pp. : 284-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomics, Evidence, and the Role of Payers

By  

Public Health Genomics, Vol. 12, Iss. 3, 2009-02 ,pp. : 149-157

Karger

Access to resources Recommend Favorite

ACCE, Pharmacogenomics, and Stopping Clinical Trials: Time to Extend the CONSORT Statement?

By Ozdemir Vural   Joly Yann   Knoppers Bartha  

American Journal of Bioethics, Vol. 11, Iss. 3, 2011-03 ,pp. : 11-13

Routledge Ltd

Access to resources Recommend Favorite

Clinical Application of Pharmacogenomics: The Example of HLA-Based Drug-Induced Toxicity

By  

Public Health Genomics, Vol. 17, Iss. 5-6, 2014-10 ,pp. : 248-255

Karger

Access to resources Recommend Favorite

On the Role of Clinical Genetics in 2010

By  

Public Health Genomics, Vol. 4, Iss. 2, 2001-11 ,pp. : 81-83

Karger

Access to resources Recommend Favorite

DruGeVar: An Online Resource Triangulating Drugs with Genes and Genomic Biomarkers for Clinical Pharmacogenomics

By  

Public Health Genomics, Vol. 17, Iss. 5-6, 2014-09 ,pp. : 265-271

Karger

Access to resources Recommend Favorite